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Store-operated Ca2 channels (SOCs) mediate receptor-stimu-
lated Ca2 influx. Accumulating evidence indicates that members
of the transient receptor potential (TRP) channel family are com-
ponentsofSOCsinmammaliancells.Agonist stimulationactivates
SOCs and TRP channels directly and by inducing translocation of
channels in intracellular vesicles to the plasma membrane (PM).
Themechanismof TRP channel translocation in response to store
depletion and agonist stimulation is not known. Here we use
TRPC3 as amodel to show that IP3 and the scaffoldHomer 1 (H1)
regulate the rate of translocation and retrieval of TRPC3 from the
PM. In resting cells, TRPC3 exists in TRPC3-H1b/c-IP3Rs com-
plexes that are located in part at thePMand in part in intracellular
vesicles. Binding of IP3 to the IP3Rs dissociates the interaction
between IP3Rs and H1 but not between H1 and TRPC3 to form
IP3Rs-TRPC3-H1b/c.TIRFMandbiotinylationassaysshowrobust
receptor- and store-dependent translocation of the TRPC3 to the
PM and their retrieval upon termination of cell stimulation. The
translocationrequiresdepletionof storedCa2and ispreventedby
inhibition of the IP3Rs. In HEK293, dissociating the H1b/c-IP3R
complexwithH1aresults inTRPC3translocationtothePM,where
it is spontaneously active. The TRPC3-H1b/c-IP3Rs complex is
reconstituted by infusing H1c into these cells. Reconstitution is
inhibitedby IP3.DeletionofH1 inmicemarkedly reduces the rates
of translocation and retrieval of TRPC3. Conversely, infusion of
H1c into H1/ cells eliminates spontaneous channel activity and
increases the rate of channel activationby agonist stimulation.The
effectsofH1care inhibitedbyIP3.These findings togetherwithour
earlier studies demonstrating gating of TRPC3 by IP3Rswere used
to develop amodel in which assembly of the TRPC3-H1b/c-IP3Rs
complexes by H1b/c mediates both the translocation of TRPC3-
containing vesicles to the PM and gating of TRPC3 by IP3Rs.
Ca2 influx is a critical component of the receptor-evoked
Ca2 signal and plays a role inmany physiological functions (1).
The best described form of Ca2 influx is mediated by the
store-operated Ca2 channels (SOCs),3 which are activated
by agonist-dependent or agonist-independent depletion of
Ca2 stored in the ER (1). The molecular identity of the SOCs
and Icrac is still not known with certainty, although recent work
points to ORAI1/CRACM1/olf186-F as a potential Icrac (2–5).
However, accumulating evidence indicates thatmembers of the
transient receptor potential (TRP) family of ion channels are
associated with SOCs in mammalian cells. Thus, deletion of
TRPC4 inmice (6, 7) or of TRPC1, TRPC3, TRPC6, andTRPC7
by antisense or siRNA (8–10) and dominant negative TRPC1,
TRPC3, or TRPC5 (11–14) partially inhibit SOCs and/or recep-
tor-stimulated Ca2 influx.
Themechanism by which agonist stimulation activates Ca2
influx by TRPC channels is not well understood. TRPC1, -4,
and -5 can be activated by store depletion, whereas TRPC3, -6,
and -7 can be activated by the lipid diacylglycerol (11, 15, 16).
However, depending on cell type and expression levels, TRPC3
can also be activated by store depletion (17–19). Several mech-
anisms have been proposed to explain how store depletion
leads to activation of SOCs and TRPC channels; conforma-
tional coupling between TRPC channels and IP3 receptors
(IP3Rs) (18, 20–22), exocytotic insertion of the channels in the
plasma membrane (PM) (23–25), and activation by a diffusible
messenger (26, 27). Biochemical and functional evidence
showed regulatory interaction between IP3Rs and several TRPC
channels, including TRPC1 and TRPC3 (18, 28–32). The inter-
action betweenTRPC1 and IP3Rs and gating of TRPC1by IP3Rs
is mediated by Homers (33). Homers are scaffolding proteins
that bind many Ca2-signaling proteins, including all TRPC
channels and IP3Rs (33–37). In addition, a C-terminal domain
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of several TRPC channels directly interacts with an N-terminal
sequence in the IP3Rs (28, 32) that participates in gating of
TRPC channels by IP3Rs (30, 32).
A newly discovered and apparently a general regulatory
mechanism of TRPC channel activity is agonist-stimulated
translocation of the channels to the PM. In HEK293 cells,
receptor stimulation but not passive store depletion was
reported to stimulate the translocation of TRPC3 to the PM in
amechanism thatwas inhibited by cleavage of VAMP2 (vesicle-
associated membrane protein 2) with tetanus toxin (38).
Another form of regulation of TRPC3 is by interaction with
phospholipase C (22, 39). However, unlike the role of VAMP2,
phospholipase C does not affect the acute expression or trans-
location of TRPC3 but rather the steady-state level of TRPC3 in
the PM (22). Stimulation of the epidermal growth factor recep-
tor resulted in translocation of TRPC5 to the PM in a mecha-
nism that was dependent on phosphoinositide 3-kinase, the
Rho GTPase Rac1, and phosphatidylinositol-4-phosphate 5-ki-
nase (PIP(5)K) (24). Finally, stimulation of the muscarinicM3
receptor resulted in translocation of TRPC6 to the PM in a time
course that coincides with activation of Ca2 influx (25).
For the most part, TRPC channel translocation has been
studied in cell lines. Whether such a mechanism also operates
in native cells is not known. Furthermore, TRPC3, -5, and -6
bind Homers and IP3Rs (33) (present work). The potential role
of Homer and IP3Rs in this form of regulation of TRP channels
activity is not known. Here, we used cells transfected with
TRPC3 and Homer 1 (H1) isoforms and cells prepared from
WT and H1/ mice to report that H1 regulates the agonist-
and store-dependent translocation and antagonist-mediated
retrieval of TRPC3 from the PM. This process requires the dis-
sociation of the IP3Rs-H1-TRPC3 complex by binding of IP3 to
the IP3Rs. These findings suggest a novel mechanism by which
store depletion leads to activation of TRPC channels and Ca2
influx.
EXPERIMENTAL PROCEDURES
Materials and Solution—Anti-TRPC3 antibodieswere a gen-
erous gift fromDr.CraigMontell (JohnsHopkinsUniversity) or
batch 2 fromAlomone (Jerusalem, Israel). Anti-IP3R3 antibod-
ies were from BD Transduction Laboratories, and anti-HA
antibodies were from Covance (Princeton, NJ). pRK5-HA-
TRPC3, pRK5-HA-Homer 1a, and pRK5-HA-Homer 1c were
prepared as detailed elsewhere (33), and pCMV-TRPC3-YFP
was generously provided byDr. ThomasGudermann (Philipps-
Universitat-Marburg, Germany). All biotinylation-related
products were purchased from Pierce.
Cell Culture, Transfection, Co-immunoprecipitation, Pull-
down Assay, and IP3 Competition Assay—M3-HEK cells stably
expressing the type 3muscarinic receptorwere cultured inDul-
becco’s modified Eagle’s medium containing 10% fetal bovine
serum and 100 units/ml penicillin and streptomycin. Cells were
transfected with Lipofectamine Plus reagent (Invitrogen) and
used 36–48 h post-transfection. For co-immunoprecipitation
(co-IP), the cells were lysed in a buffer containing a protease
inhibitormixture (Roche Applied Sciences). Lysates were incu-
bated overnight at 4 °C with anti-HA antibodies and immuno-
precipitated proteins were analyzed by SDS-PAGE. For the IP3
competition assay, M3-HEK cell lysates and pancreatic micro-
somal lysates were incubated with or without 100M IP3 for 30
min at 0 °C (ice water bath) to bind IP3 to the IP3Rs. GST,
GST-H1a, or GST-H1c coupled to beads was then added to the
extracts, and the incubation at 0 °C continued for 4–12 h. The
beads were washed with lysis buffer, and proteins were released
by incubation in SDS sample buffer. Pulled proteins were ana-
lyzed by SDS-PAGE and Western blotting. Due to the long
incubation required for the pull-down and co-IP assays (4.5
h), 100M IP3was used to ensure the presence of IP3 during the
entire incubation periods.
Isolation of Pancreatic Acinar Cells—The pancreases of 1–2
mice were removed and digested with collagenase and trypsin
to isolate single cells to improve access to biotin. Single pancre-
atic acinar cells were prepared as described before (40). Briefly,
the pancreases were finely minced and digested with 4 mg/15
ml collagenase P for 5min at 37 °C in a solution namedPSA that
contained 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2,
10mMHEPES (pH7.4withNaOH), 10mMglucose, 0.1%bovine
serum albumin, and 0.02% soybean trypsin inhibitor. The cells
were then washed with Ca2- and Mg2-free PBS and treated
for 2 min at 37 °C with 0.05% trypsin-EDTA solution (Sigma),
washed with PSA, and digested again with collagenase for 3–4
min at 37 °C. Finally, the cells werewashedwith PSA and stored
on ice until use.
Protein Extraction—Mice were scarified, and the tissues of
interest were collected. To prepare microsomes, each tissue
was washed with a buffer containing 250 mM sucrose, 10 mM
HEPES, 1 mM EDTA, 1 mM dithiothreitol, 0.2 mM phenylmeth-
ylsulfonyl fluoride and homogenized in 5 ml of buffer by 20
strokes with a Dawn’s homogenizer. After centrifugation for 3
min at 1000 rpm, the supernatants were centrifuged for 20 min
at 18,000 rpm. The microsomes were dissolved in lysis buffer
containing 20mMTris, pH 8.0, 137mMNaCl, 5mMNaEDTA, 5
mM NaEGTA, 10% glycerol, 0.5% Triton X-100, 0.2 mM phen-
ylmethylsulfonyl fluoride, 50mMNaF, 20mM benzamidine and
kept on ice for 30 min. Insoluble material was removed by
15-min centrifugation at 14,000 rpm, 4 °C, and the superna-
tants were collected. Protein concentration in the extracts was
measured by the Bradford method.
Surface Biotinylation Assay—Sulfo-NHE-ss-Biotin (Pierce)
in PBS supplemented with 1 mM MgCl2 and 0.5 mM CaCl2 was
added to control cells or cells treated with agonist, antagonist,
or CPA, and the mixtures were incubated for 30 min at 0 °C.
Free biotin was quenched by the addition of 1% bovine serum
albumin in PBS supplemented with Ca2 and Mg2, and then
the cells were washed once with PBS. Lysates were prepared in
lysis buffer by passing 7–10 times through a 27-gauge needle.
The lysates were centrifuged at 14,000 rpm for 10 min at 4 °C,
and protein concentration in the supernatants was determined.
Volume and protein content were adjusted to be the same in all
samples, and to each sample was added 10% streptavidin beads
(Pierce) in 300 l. The mixtures were incubated overnight at
4 °C, the beads were washed five times with lysis buffer, and the
proteins were extracted by suspending the beads in sample
loading buffer. Precipitated proteins were analyzed byWestern
blot.
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Immunocytochemistry—Immunostaining was performed as
detailed previously (41). Pancreatic, parotid, or submandibular
cells were immobilized on a poly-L-lysine-coated coverslip and
were permeabilized with 0.5 ml of cold methanol for 10 min at
20 °C. The samples were washed with PBS, and the nonspe-
cific sites were blocked by a 1-h incubation with a solution
containing 5% goat serum, 1% bovine serum albumin, and 0.1%
gelatin in PBS (blocking medium). The medium was aspirated
and replacedwith 50l of blockingmedium containing control
serum or a 1:50 dilution of anti-TRPC3, 1:100 dilution of anti-
IP3R3, and a 1:10 dilution of anti-ZO1 antibodies. After incu-
bation with the primary antibodies overnight at 4 °C and three
washeswith the incubation buffer, the antibodieswere detected
with goat anti-rabbit or anti-mouse IgG taggedwith fluorescein
isothiocyanate or rhodamine. Images were analyzed with a Bio-
Rad MRC 1024 confocal microscope.
TRPC3Current Recording inHEKCells—M3-HEK cells were
transfected with TRPC3 and green fluorescent protein. Whole
cell current measurement was accomplished 48 h post-trans-
fection. Cells on coverslips were placed in a perfusion chamber,
and green fluorescent protein fluorescence was used to identify
the transfected cells. The cells were perfusedwith bath solution
containing 150 mM NaCl, 4 mM KCl, 10 mM HEPES, 0.5 mM
EGTA, pH 7.4, with NaOH. Na-free bath solution contained
150 mMNMDG-Cl, 10 mMHEPES, 0.5 mM EGTA, pH 7.4 with
Tris. The pipette solution contained 140 mM NMDG-Cl, 1 mM
MgCl2, 1 mM ATP, 150 mM HEPES, 10 mM EGTA, pH 7.2 with
Tris to eliminate the native K current. The patch pipette had a
resistance of 2–4megaohms. After gigaseal (8 gigaohms) was
formed on the cell surface, the whole cell configuration was
established by gentle suction. The current was measured by
holding the membrane potential at 0 mV and sampled by a
200-ms rapid alterations of membrane potential (RAMPs)
between100 mV and60 mV. The current at100 mV was
extracted and plotted as a function of time.
Whole Cell Current Recording in Single Pancreatic Acinar
Cells—Single pancreatic acinar cells were prepared by a three-
stepmethod described previously with somemodification (42).
The mouse pancreas was minced into fine pieces of 1 mm3,
washed, and digested with collagenase type IV (40 units/ml for
6 min at 37 °C). The tissue was washed with Ca2- and Mg2-
free PBS and digested with PBS solution containing 0.025%
trypsin for 3 min at 37 °C. The tissue was washed twice with
PSA and digested with PSA containing collagenase type IV 20
units/ml for 3 min at 37 °C. Finally, the cells were filtered, sus-
pended in PSA, and kept on ice until use. The cells were per-
fused with a bath solution containing 140mMNaC1, 5mMKCl,
0.5 mM EGTA, 10 mM Hepes (pH 7.4, with NaOH) (divalent
free). The patch pipette resistance was 2–5 megaohms when it
was filled with internal solution containing 140mMNMDG-Cl,
1 mMMgCl2, 10 mM EGTA, 5 mM Na2ATP, and 10 mMHEPES
(pH7.3withTris). After a gigaseal (5 gigaohms)was obtained,
the holding potential was changed from 0 to 80 mV. The
whole cell configuration was established by a pulse of suction.
The current output from the patch clamp amplifier (Axopatch-
200B; Axon Instruments) was filtered at 20 Hz, sampled at 1
kHz, and stored in computer with a Digi-Data 1200 interface
and pclamp 8.1 software (Axon Instruments).
TIRF Analysis—TRPC3-YFP translocation was monitored in
HEK cells expressing TRPC3 alone or co-transfected with H1a.
Live cell TIRF imaging was performed with a60 objective on
a Nikon TIRF microscopy system. Images were analyzed with
MetaMorph software (Universal Imaging).
RESULTS ANDDISCUSSION
H1a Translocates TRPC3 to the PlasmaMembrane—Homer
1a (H1a) has an EVH domain but lacks the multimerizing
coiled-coil and leucine zipper domains and dissociates com-
plexes formed by dimerizing H1b/c. H1a is thus a useful tool to
study the role of Homer proteins in Ca2 signaling (33). The
role of Homer in agonist-mediated translocation of TRPC3 to
the plasma membrane (PM) was evaluated by TIRF in HEK293
cells expressing the muscarinic M3 receptors and transfected
with TRPC3-YFP or TRPC3-YFP and H1a. The images in Fig.
1A and the time lapse movies in the supplement show that a
significant portion of TRPC3 was found in intracellular ves-
icles. Stimulation with carbachol resulted in a rapid disap-
pearance of the vesicles as they fused with the PM. The rapid
fusion precluded observing accumulation of the vesicles at
the PM, but this was confirmed by surface biotinylation
assays in Fig. 1B. Removal of carbachol and treatment of the
cells with atropine resulted in partial recovery of the vesicles
within 40 s of the treatment with atropine. Expression of H1a
inhibited translocation of TRPC3-YFP that remained in
intracellular vesicles. However, the frequency of finding
intracellular vesicles was low, and when found, the vesicles
appeared smaller (average size of vesicles in the presence of
H1a was 61  4% (n  32) smaller than in the absence of
H1a). These vesicles were not translocated to the PM upon
agonist stimulation.
The effect of H1a was quantitated by a biotinylation assay to
measure the surface expression of TRPC3. Fig. 1B shows that
cell stimulation resulted in rapid translocation of TRPC3 to the
PM. Expression of H1a increased the level of TRPC3 present at
the PM of resting cells to a level caused by cell stimulation.
Subsequent stimulation of cells expressing H1a resulted in only
a small further increase in PM expression of TRPC3. The
dimerizingH1b increased the total cellular level of TRPC3, per-
haps by decreasing degradation of the channel, but did not
change its surface expression at the resting state or its translo-
cation to the PM by cell stimulation. Similar results were
observed with TRPC3-YFP (not shown).
The functional consequences of the effects of H1a and H1b
on TRPC3 translocation are depicted in Fig. 1, C–E. Fig. 1C
shows examples of current traces, Fig. 1D shows the typical
TRPC3 I/V in TRPC3-transfected cells, and Fig. 1E is the sum-
mary. HEK293 cells transfected with empty vector, H1a alone,
or H1b alone did not show a typical TRPC3 current (Fig. 1, C
and D). Resting HEK293 cells expressing TRPC3 showed very
small spontaneous TRPC3-specific current. Stimulation of the
M3R resulted in activation of TRPC3. In the presence of H1a,
mostly spontaneous TRPC3 current was detected, consistent
with PM localization of the channel and indicating that TRPC3
was fully active in the presence of H1a. H1b only increased the
stimulated activity of TRPC3 (Fig. 1C, red trace), as expected
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from increased expression of the channel and receptor-medi-
ated translocation to the PM.
IP3 Dissociates IP3Rs-H1 Interaction—Co-IP experiments
showed that expression of H1b/c increases, whereas expres-
sion of H1a decreases, the co-IP of TRPC3 and IP3 receptors
(not shown), suggesting that H1b/c assembles and H1a dis-
sociates TRPC3-H1b/c-IP3Rs complexes. The question that
arises is how disassembly of the complexes occurs under
physiological conditions and its role in regulating TRPC3
activity. A clue was provided by a recent crystal structure of
the ligand-binding suppressor domain of the IP3R1, which
showed that the Homer binding motif of the IP3Rs is adja-
cent to the IP3 binding core (43). We reasoned that binding
of IP3 to activate the IP3Rs and evoke Ca2 release from the
stores may also allosterically inhibit binding of H1 to the
IP3Rs and dissociate the TRPC3-H1b/c-IP3Rs complexes.
The pull-down (PD) assays in Fig. 2A indicate that this is the
case. GST-H1a and GST-H1c specifically pulled down the
native IP3R3 and transfected TRPC3. Remarkably, the addi-
tion of IP3 inhibited the binding of both H1a and H1c to the
IP3 receptors but did not affect the binding of the Homers to
TRPC3.
To determine the functional significance of H1b/c-IP3R dis-
sociation by IP3, wemeasured the effect of IP3 onmodulation of
the TRPC3 current by the Homers. Maximal activation of
TRPC3 by H1a was verified by showing that infusion of 100 M
IP3 into cells expressing H1a and TRPC3 did not further acti-
vate the channel (Fig. 2C). Importantly, infusing the TRPC3
H1a-expressing cells with recombinant multimerizing H1c
recoupled TRPC3 to reduce the spontaneous activity and
increase the receptor-activated portion of the current to that
found in control cells (Fig. 2D). Most notably, IP3 completely
inhibited the effect of H1c (Fig. 2E), as expected from inhibition
of binding of H1c to the IP3Rs by IP3 (Fig. 2A). The recoupling
indicates that after dissociation of the complex by cell stimula-
tion and binding of IP3 to the IP3Rs, the channels remain in
FIGURE 1.H1a translocates TRPC3 to the plasmamembrane. A, HEK293 cells transfected with TRPC3-YFP (left images) of TRPC3-YFP and H1a (right images)
were stimulated with 100 M carbachol for 60 s and then inhibited with 10 M atropine for 40 s, and TIRF fluorescence was recorded. B, biotinylation assay.
HEK293 cells transfected with HA-TRPC3 (all blots), H1a (middle blot), or H1b (lower blot) were stimulated with 100 M carbachol for the indicated times, and
surfaceTRPC3wasassayedbybiotinylationasdetailedunder “Experimental Procedures.” The columnsare the summaryof threeexperiments showing the -fold
increase in TRPC3 at theplasmamembrane relative to the level in control, unstimulated cells. The resultswere corrected for input of TRPC3 and show thatmost
TRPC3 was in the plasma membrane of resting cells expressing TRPC3 and H1a. C–E, channel function. The whole cell current was measured at a holding
potential of100mV in cells transfectedwith TRPC3alone (C ), H1a alone (solid blue symbols), TRPC3 andH1a (openblue symbols), H1b alone (solid red symbols),
or TRPC3 andH1b (open red symbols), as indicated. Spontaneous currentwasmeasured by incubating resting cells withmedia containingNa of NMDG, and
then the cells were stimulated with 100 M carbachol to record the stimulated TRPC3 current, as evident from the I/V plots in D. The summary in E is of
spontaneous (Spon; green) or agonist-stimulated current (Carb; blue) at100 mV from 4–6 cells, which were normalized for cell capacitance (pA/picofarads)
and averaged to obtain the mean S.E.
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close proximity to allow the recoupling. This point will be fur-
ther addressed below.
TRPC3 Is Expressed at the Lateral Pole of Polarized Cells—
The results in Figs. 1 and 2 suggest that Homers play a role in
translocation of TRPC3 to the PM and regulation of its activ-
ity. To extend these findings to the in vivo situation, we used
pancreatic and salivary gland cells, which express high levels of
TRPC3. Fig. 3 shows that TRPC3 is expressed mainly at the
lateral membrane and next to the apical pole of all cells exam-
ined. Previous work used immunohistochemistry to suggest
that TRPC3 may be expressed at the luminal membrane of the
submandibular gland (44). Themore sensitive immunofluores-
cence localization in Fig. 3B shows concentration ofTRPC3 and
IP3Rs at the junctional site at the apical pole (yellow arrow-
heads), expression at the lateral and basal poles (white arrow-
heads), and weak expression at the luminal membrane. Trans-
fection in Madin-Darby canine kidney cells grown on
permeable support confirmed targeting ofTRPC3mainly to the
basolateral membrane, proximal to ZO1 and the same as
-catenin (Fig. 3C). The same localization was found with four
different anti-TRPC3 antibodies (Montell, Schilling, Alomone,
and Sigma).
The specificity of the antibodies
used for the staining, the co-IP, and
the biotinylation experiments is
shown in Fig. 3D. The anti-TRPC3
antibodies detected a single band of
about 78 kDa in 37 g of brain and
pancreatic extracts. Moreover, the
antibodies detected a single band in
6 g of extract prepared from
HEK293 cells transfected with
TRPC3-YFP. The anti-IP3R3 anti-
bodies detected a single band of
about 270 kDa in pancreatic and
HEK293 cell extracts and two bands
in HEK293 cells transfected with
green fluorescent protein-IP3R3
(Fig. 3D). Hence, the antibodies
used in the present work had the
required specificity. The Co-IP
experiments in Fig. 3E show that in
secretory cells and the brain, TRPC3
exists in complexes with IP3Rs
and the plasma membrane Ca2
ATPase pump (PMCA).
Receptor- and Store-dependent
Translocation of TRPC3 to the PM—
Abiotinylation assay was used to fol-
low TRPC3 translocation in native
cells. Fig. 4A shows that some
TRPC3 is present at the PM of rest-
ing cells and that stimulation of the
Gq-coupled M3 receptors resulted
in a robust translocation of TRPC3
to the PM. Significantly, termina-
tion of cell stimulation with atro-
pine resulted in retrieval of TRPC3
from the PM. The state of the interaction of IP3Rs with TRPC3
at the PM was assayed by biotinylation. Fig. 4B shows that in
unstimulated cells, some IP3Rs were pulled down by the avidin
beads, probably by binding to surface proteins, such as TRPC3.
The specificity of the biotinylation is shown by the lack of pull-
down of the cytoplasmic protein aldolase. Cell stimulation
reduced the amount or the strength of interaction of IP3Rs with
surface proteins. Again, the reduced interaction was reversed
by subsequent inhibition of cell stimulationwith atropine, indi-
cating that after the dissociation by cell stimulation, the IP3Rs
remain in close proximity toTRPC3 at the PM.That at least one
of the PM proteins interacting with IP3Rs is TRPC3 is shown in
Fig. 4C, which shows that IP of TRPC3 co-immunoprecipitated
IP3R3, the co-IPwas reduced by cell stimulation, and the IP3Rs-
TRPC3 complex was reformed by inhibition of carbachol-stim-
ulated cells with atropine.
Although several studies (17, 19, 28, 45, 46), including ours
(18, 30), suggested that TRPC3 can function as SOCs, others
concluded that this is not the case (15, 47, 48). However, the
behavior of TRPC3 in native cells was examined before only in
one study using pontine neurons from P3–P8 rats. In these
cells, activation of TRPC3 required IP3-mediated Ca2 release,
FIGURE 2. Functional consequences of inhibition by IP3 of Homers binding to the IP3R. A, the blots show
inhibition by IP3 of H1a and H1c binding to the IP3R. Extracts prepared from HEK293 cells transfected with
TRPC3 were incubated at 0 °C with and without 100 M IP3 and were used to pull down TRPC3-H1b/c-IP3Rs
complexes by beads boundwithGST alone (control), GST-H1a, or GST-H1b. Binding of IP3 to the IP3Rs inhibited
the binding and pulldown (PD) of IP3Rs by H1a and H1b. B–E, whole cell current wasmeasured in HEK293 cells
transfectedwith TRPC3 andH1a (B–E). The cells were also infusedwith 100M IP3 to show that, once activated
byH1a, the current is no longer sensitive to storedepletion (C). Cells expressingTRPC3H1awere infusedwith
50g of recombinant H1c (D) or H1c and 100M IP3 to inhibit binding of H1c to the IP3Rs. Inward current was
measured at a holding potential of100mV, andmonovalent cation currentwas evaluated by incubating the
cells in medium containing 150 mM NMDG or Na and resting or stimulated with 100 M carbachol. F,
summary of spontaneous or agonist-stimulated current from 8–13 cells under each condition.
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although the channel could not be activated by treating the cells
with thapsigargin (49). Here we examined the role of Ca2
stores in the translocation of TRPC3. Fig. 4,A andB, shows that
store depletion with the SERCA pump inhibitor CPA was as
effective as agonist stimulation in causing TRPC3 translocation
to the PM and in altering its interaction with IP3Rs.
TRPC3 translocation was dependent on both IP3Rs and
depletion of storedCa2. Store depletionwithCPA reduced the
co-IP of IP3Rs and TRPC3 in native cells (Fig. 4C). Further-
more, Fig. 4D shows that inhibition of the IP3Rs with xesto-
spongin C (Xest C) inhibited the agonist- and CPA-mediated
translocation of TRPC3 to the PM. Since inhibition of SERCA
pumps with CPA depletes the Ca2 stores also in the presence
of Xest C, inhibition of TRPC3 translocation by CPA indicates
that the translocation required functional IP3Rs. The protocol
of Fig. 4E was designed to show that TRPC3 translocation and
retrieval were dependent on Ca2 content of the stores. Acinar
cells were incubated in Ca2-free medium and stimulated with
carbachol to deplete stored Ca2, which resulted in the usual
translocation of TRPC3 to the PM. Inhibition by atropine while
the cells were kept in Ca2-free medium to prevent store
reloading inhibited retrieval of TRPC3. The subsequent addi-
tion of Ca2 to the medium to reload the stores resulted in
retrieval of TRPC3 from the PM.We have previously used the
same protocol to show that SOCs remained fully active as
long as the stores were not allowed to reload with Ca2 and
were inhibited only when the stores were reloaded with Ca2
(50, 51).
The implication of the results in Figs. 3 is that translocation
of TRPC3 to the PM is dependent on IP3Rs and on store Ca2
content. This indicates that (a) in vivoTRPC3 behaves as SOCs,
(b) TRPC3 is a subunit of SOCs, and (c) in vivo the TRPC3-
FIGURE 3. Basolateral localization of TRPC3. Large clusters of pancreatic (A) and parotid (B, left) acini or submandibular duct (B, right) were co-stained for
TRPC3 (green) and ZO1 (A) or IP3Rs (A and B, red). The yellow arrowheads in the duct mark expression of TRPC3 at the apical pole junctions, and the white
arrowheads mark the basolateral membrane. In C, HA-TRPC3 was expressed in polarized Madin-Darby canine kidney cells, and the cells were co-stained for
TRPC3 (green) and ZO1 (upper images) or -catenin (lower images) (red). In each panel, the upper image is the x/y scan at the apical region, and the lower image
is the z scan.D shows thehigh specificity of the antibodies used in thepresentwork as revealedbyblotting for TRPC3 (left) and IP3R3 (right) of extracts prepared
from the mouse brain and pancreas (panc) from untransfected HEK293 cells of HEK293 cells transfected with TRPC3-YFP or green fluorescent protein (GFP)-
IP3R3, as indicated. In E, native TRPC3 (left) or plasmamembraneCa
2ATPasepump (PMCA) (right) was immunoprecipitated, and theprecipitateswereprobed
for TRPC3 and IP3Rs (left) or TRPC3 and PMCA (right).
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associated SOCs are regulated in part by translocation to the
PM.
Homer 1 Regulates the Rate of TRPC3 Translocation and
Retrieval—The role ofHomers in agonist- and store-dependent
TRPC3 translocation to the PMwas examined using pancreatic
acinar cells from WT and H1/, H2/, and H3/ mice.
Deletion of Homer 2 and Homer 3 had no apparent effect on
TRPC3 translocation (not shown), indicating that the effects
described below are specific to Homer 1 (H1). Deletion of H1
had no effect on overall expression of TRPC3 but reduced the
steady-state level of TRPC3 at the PM by about 50% (Fig. 5A).
This is probably an adaptation to reduce the spontaneous activ-
ity of TRPC3 at the PM (see Ref. 33) (see below). Stimulation of
H1/ cells resulted in translocation of TRPC3 to increase its
level at the PM to that found in stimulatedWT cells. However,
store depletion by CPAwas less effective in stimulating TRPC3
translocation in H1/ cells. Furthermore, inhibition of cell
stimulation by atropine for 3 min resulted in only partial
retrieval of TRPC3 from the PM.
To determine the reason for the poor TRPC3 translocation
stimulated by store depletion and its poor retrieval on termina-
tion of cell stimulation in H1/ cells, we compared the time
course of the translocation and retrieval of TRPC3 in WT and
H1/ cells. Fig. 5B shows that most TRPC3 translocation was
completedwithin 30 s of stimulationwith agonist, whereas little
translocation was measured after 30 s of treatment with CPA.
Comparable translocation was measured after 5 min of treat-
ment with agonist or CPA, consistent with the fast and slow
depletion of the Ca2 stores by agonist stimulation and inhibi-
tion of SERCA pump, respectively. Fig. 4B shows that deletion
FIGURE 4. IP3Rs- and store-dependent translocation and retrieval of
TRPC3 from theplasmamembrane.A, pancreatic acinar cells fromWTmice
were stimulated with 1 mM carbachol or treated with 30 M CPA for 5 min or
stimulated with carbachol for 2 min and inhibited with 10 M atropine for 3
min. The cell surface proteins were biotinylated, and extracts were prepared
to pull down and analyze plasma membrane levels of TRPC3. The columns
show a summary of 4–5 experiments. *, p 0.01 relative to unstimulatedWT
cells. B, the same protocol as in A was used, except that the blots were ana-
lyzed for IP3R3. For a control, the blotswere analyzed for the cytosolic protein
aldolase.C, extractswereprepared fromacini treated as inA andwereused to
immunoprecipitate TRPC3 and blot for IP3R3 to assay for co-IP of IP3Rs and
TRPC3.D, the sameprotocol as inAwasused, except that a portionof the cells
was treated with 5 M xestospongin C (Xest C ) for 10 min before treatment
with carbachol or CPA. The columns summarize the results of three similar
experiments. E, effect of store Ca2 content on TRPC3 retrieval. Cells in Ca2-
free mediumwere stimulated with carbachol for 5 min (Car/0Ca) or with car-
bachol for 2min and inhibitedwith atropine for 3min (Car/Atr/0Ca). Ca2 to a
final concentration of 2 mM was added to cells treated with carbachol and
atropine in Ca2-free medium, and the incubation continued for an addi-
tional 3min (Car/Atr/0Ca/Ca). The cellswere thenused todetermine surface
expression of TRPC3. The columns show the summary of three similar exper-
iments. *, p 0.01 relative to unstimulated cells; #, p 0.05 relative to Car/
Atr/0Ca cells. Con, control.
FIGURE 5. H1 facilitates IP3Rs- and store-dependent translocation and
retrieval of TRPC3 from the plasma membrane. A, pancreatic acinar cells
from H1/mice were treated as in Fig. 4A, and plasma membrane levels of
TRPC3wereanalyzedbybiotinylation. The columns showthe summaryof 4–5
experiments. *, p  0.01 relative to unstimulated WT cells; #, p  0.05 from
unstimulated H1/ cells. B, effect of H1 on time course of TRPC3 transloca-
tion. WT (●) and H1/ acinar cells (‚) were stimulated with 1 mM carbachol
(● and‚) or treated with 30M CPA () for the indicated times, and surface
TRPC3 was determined by biotinylation. B shows a typical blot and the sum-
mary of 4–5 similar experiments. C, effect of H1 on time course of TRPC3
retrieval. WT () and H1/ acinar cells (●) were stimulated with 1 mM car-
bachol for 5 min, and samples were removed to determine surface level of
TRPC3 before termination of cell stimulation with 10 M atropine. Samples
were removed at the indicated times to measure the rate of TRPC3 retrieval.
Con, control.
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of H1 markedly reduced the rate of TRPC3 translocation in
response to agonist stimulation. Furthermore, Fig. 5C shows
that deletion of H1 also reduced the rate of TRPC3 retrieval
initiated by atropine inhibition of stimulated cells. Thus, the
combined results in Fig. 5 show that H1 regulates the rate of
stores and IP3Rs-mediated translocation and retrieval of
TRPC3.
Functional Correlate—To determine the relationship between
IP3Rs,H1andTRPC3 innative cells,wemeasured the effect of IP3
on the interaction between the proteins. As was found in
HEK293 cells (Fig. 2A), GST-H1a and GST-H1c specifically
pulled down TRPC3 and IP3R3 from pancreatic acinar cell
extracts, and binding of IP3 to the IP3Rs dissociated the Hom-
ers-IP3Rs interaction without dissociating the Homers from
TRPC3 (Fig. 6A). Similar results were also obtained by pull-
down (not shown) and co-IP from
brain extract (Fig. 6B). Brain extract
was used for the co-IP experiments,
since the level of H1 in the pancreas
was low and could not be reliably
detected in the immunoprecipitate.
Fig. 6B shows that IP of IP3Rs co-
immunoprecipitated TRPC3 and
H1, and binding of IP3 to the IP3Rs
reduced the co-IP of TRPC3 andH1
with the IP3Rs.
TRPC3 functions as a nonselec-
tive monovalent cation channel (18,
52). Therefore, we measured the
properties of the monovalent cation
current in WT and H1/ acinar
cells. The cells were dialyzedwith 10
mM EGTA to inhibit all Ca2-acti-
vated currents, prevent inhibition of
TRPC3 current by [Ca2]i, and
facilitate store depletion. Fig. 5C
shows that resting WT cells have a
small spontaneous cation current,
and cell stimulation prominently
and rapidly activated the current.
Interestingly, infusion of IP3 (Fig.
6D) or recombinant H1a (Fig. 6E)
maximally activated the same cation
current, as evident from the mini-
mal effect of agonist stimulation
after activation of the current by IP3
or H1a.
Parallel measurement in H1/
cells showed that about half of the
cation current was spontaneously
active in these cells. Stimulation of
H1/ cells resulted in further acti-
vation of the current. However, the
current was only slowly activated,
consistent with the slow transloca-
tion of TRPC3 to the PM shown in
Fig. 5B. The most significant find-
ings for the purpose of the present
discussion are shown in Fig. 6, G and H, and are summaries in
Fig. 6, I and J. Fig. 6G shows that infusion of recombinant dimer-
izing H1c recoupled the current to reduce the spontaneous and
increase the receptor-stimulated current. In addition, H1c
increased the rate of current activation by agonist (Fig. 6J), as
expected from the effect of H1 on the rate of TRPC3 transloca-
tion. Fig. 6H shows that IP3 completely inhibited the effect of
H1c, as predicted from inhibition of binding ofH1c to the IP3Rs
by IP3 shown in Fig. 6A.
Pancreatic acinar cells express TRPC3, TRPC6, and probably
other TRP channels. Preliminary studies showed that TRPC3
and TRPC6 exist in Ca2 signaling complexes with other
Ca2-signaling proteins, including IP3Rs and Homers (not
shown). The excellent agreement between regulation of
recombinant TRPC3 by Homers and IP3Rs in HEK293 cells
FIGURE 6. Functional consequences of inhibition by IP3 of Homers binding to the IP3 in native cells. A,
inhibition by IP3 of H1a and H1c binding to the IP3Rs. Extracts prepared from the pancreas were incubated at
0 °C with and without 10 M IP3 and used to form and pull down TRPC3-H1b/c-IP3Rs complexes by beads
coupled to GST alone (control), GST-H1a, or GST-H1b. Binding of IP3 to the IP3Rs inhibited the binding and
pulldown (PD) of IP3 receptors, but not of TRPC3, byH1a andH1b.B, effect of IP3 on co-IP of IP3Rs-H1. IP3Rswere
immunoprecipitated frombrain extracts incubated in thepresenceor absenceof IP3, and theprecipitateswere
probed for co-IP of TRPC3 and H1. In the control, anti-IP3Rs antibodies were not added. C–H, WT (C–E) and
H1/ (F–H) pancreatic acinar cells were used to measure the monovalent cation current at60 mV using a
pipette solution containing 10 mM EGTA and bath solutions containing 150 mM Na or NMDG. Where indi-
cated by the bars, the cells were stimulated with 1 mM carbachol (Carb). C, the WT control (Con). The pipette
solution contained 10M IP3 in D and 50g of H1a in E to show that agonist stimulation, store depletion with
IP3, and H1a activate the same current. F, the control for H1
/ cells, showing the increased spontaneous
current and the slowagonist-dependent activationof the residual current. InG, the cellswere infusedwithH1c,
which reduced the spontaneous current and increased the size and the rate of current activation by agonist
stimulation. Theportionof the current activatedby agonist in F (black trace) andG (gray trace)was rescaled and
is replotted in J, which also shows the summary of t1⁄2 for current activation inWT, H1
/ cells, and H1/ cells
infused with H1c in 6–9 experiments. In H, the cells were infused with H1c and 10 M IP3, which inhibited the
effect of H1c. I summarizes the spontaneous (dotted columns) and agonist-activated current (filled columns)
under each condition. ***, p 0.01 fromWT control; **, p 0.05 relative toWT control; #, p 0.05 from control
H1/ cells; ##, p 0.01 fromH1c in H1/ cells.
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and native TRPC3 in pancreatic and salivary gland cells,
including properties of the nonselective monovalent cation
current, suggest that TRPC3 is a major component of SOCs in
native cells and that other TRP channels that participate in
SOCs are likely to be regulated by H1. Previous work with
TRPC3 and TRPC6 expressed individually in HEK293 cells
concluded that both channels do not behave as SOCs (15). Fur-
thermore, TRPC3 and TRPC6 did not translocate to the PM in
response to store depletion (25, 38). The present findings
emphasize the need to study the TRPC channels in vivo to
understand their physiological behavior and contribution to
Ca2 influx. In vivo TRPC3 behaves as SOCs and appears to
contribute to agonist-stimulated and store-dependent Ca2
influx.
The key findings of the present work are that binding of IP3
to the IP3Rs inhibited binding of H1 to the IP3Rs to disas-
semble the TRPC3-H1b/c-IP3Rs complexes and that H1 reg-
ulates the rates of translocation and retrieval of TRPC3 from
the PM. At the same time, in a previous work we showed that
IP3R (18) and its N-terminal domain (30) bound with IP3 acti-
vate TRPC3. TRPC3- and IP3R-interacting domains were sub-
sequently identified (28), and the IP3R domain that binds to
TRPC3 was sufficient to activate TRPC3 (32). Since cell stimu-
lation and binding of IP3 to IP3Rs result in dissociation of H1
from IP3Rs and reduced interaction of IP3Rs with TRPC3, we
propose that H1 may have two roles in controlling TRPC3
activity: facilitation of TRPC3 translocation and retrieval from
the PM and strengthening of the interaction and gating of
TRPC3 by IP3Rs. The model in Fig. 7 attempts to account for
both effects of H1. In resting cells, TRPC3 exists in a complex
with H1 and IP3 receptors. IP3Rs and TRPC3 also interact
directly, and this interaction is stabilized by H1. While in the
complex, TRPC3 is not active, whether the TRPC3-H1b/c-
IP3Rs complex is at the PM or in intracellular vesicles. IP3 gen-
erated by receptor stimulation binds to the IP3Rs to release
Ca2 from the stores and dissociate between IP3Rs and H1 to
form the IP3Rs-TRPC3-H1b/c complex, in which interaction
between IP3Rs-TRPC3 is flexible and is not maintained in
extracts of stimulated cells or extracts incubated with IP3.
The IP3Rs-TRPC3-H1 complex rapidly translocates to the
PM. The IP3Rs-TRPC3-H1b/c complex is active and mediates
Ca2 influx. Maintained binding of IP3 to the IP3Rs and inter-
action of IP3Rs with TRPC3 is required for activation of TRPC3
(18, 28, 30, 32). H1a can also dissociate the IP3Rs-H1-TRPC3
complexes to form IP3Rs-TRPC3-H1a complexes that translo-
cate and fuse with the PM. As long as the IP3Rs is bound with
IP3, it does not bind to H1, and TRPC3 remains active at the
PM. Termination of cell stimulation results in hydrolysis of IP3,
reloading of the stores with Ca2, restoration of binding of H1
to IP3Rs, and stabilization of the TRPC3-H1b/c-IP3Rs com-
plexes and retrieval of TRPC3 from the PM.
Recent studies identified STIM1 (stromal interaction mole-
cule-1) as a sensor of ER Ca2 stores that is essential for ago-
nist- and store-dependent activation of Icrac (53) and SOCs (54,
55). Cell stimulation translocates STIM1 from the ER to the PM
(53). Hence, regulation of SOCs by STIM1 andH1 are probably
two different modes of channel regulation.
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